Atricure Inc. (ATRC)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

First
<< Previous
31 - 39

Douglas Braunstein's Hudson Executive Capital Selling Atricure Inc. (ATRC)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d...

Keep Reading →

October 10th, 2018 - Hedge Funds News

AtriCure Inc. (ATRC) Hedge Funds Are Snapping Up

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30.

Keep Reading →

December 8th, 2016 - Hedge Funds News

The Stock Picks of This Obscure Hedge Fund Returned 70.5% In 2015; See What It's Betting On in 2016

Although Los Angeles-based, biotech-focused hedge fund DAFNA Capital Management has been in operation for the past 17 years, chances are that very few people have heard its name.

Keep Reading →

March 1st, 2016 - Hedge Fund Analysis Hedge Funds News

What Do Hedge Funds Think of AtriCure Inc. (ATRC)?

The worries about the economic slowdown in China and the ongoing uncertainty about the path of interest-rate increases triggered several waves of equity sell-offs during the third quarter.

Keep Reading →

November 30th, 2015 - Hedge Funds News

Hedge Funds Are Buying Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds' portfolio at the end of March.

Keep Reading →

July 8th, 2013 - News

This Metric Says You Are Smart to Sell Derma Sciences Inc (DSCI)

Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds' portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm from smart money lately.

Keep Reading →

June 26th, 2013 - News

AtriCure Inc. (ATRC): Are Hedge Funds Right About This Stock?

In today’s marketplace, there are tons of indicators market participants can use to monitor the equity markets. A couple of the most underrated are hedge fund and insider trading sentiment.

Keep Reading →

June 19th, 2013 - News

BIOLASE Inc (BIOL) Shareholders: Have You Seen This Crucial Data?

BIOLASE Inc (NASDAQ:BIOL) was in 4 hedge funds' portfolio at the end of the fourth quarter of 2012. BIOL shareholders have witnessed a decrease in enthusiasm from smart money in recent months.

Keep Reading →

April 29th, 2013 - News